Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Boston Scientific Corp (NYSE:BSX)

22.39
Delayed Data
As of May 25
 -0.14 / -0.62%
Today’s Change
14.18
Today|||52-Week Range
23.01
+21.42%
Year-to-Date
ResMed: Positive CAT-HF Study Results to Drive ASV Sales
May 25 / Zacks.com - Paid Partner Content
STERIS (STE) Misses on Q4 Earnings, Higher Tax a Concern
May 19 / Zacks.com - Paid Partner Content
Edwards Lifesciences: Q1 Strong, TAVR Prospects Bright
May 25 / Zacks.com - Paid Partner Content
Edwards Lifesciences Presents Positive Data on Sapien3
May 18 / Zacks.com - Paid Partner Content
Genomic Health (GHDX): Q1 Results Strong, Costs Escalate
May 24 / Zacks.com - Paid Partner Content
Bruker: Q1 Results Strong, Product Launches Hold Promise
May 17 / Zacks.com - Paid Partner Content
STERIS (STE): Q4 Results Strong, Currency Woes Remain
May 23 / Zacks.com - Paid Partner Content
Myriad Genetics Brings myVectra Web Portal for RA Patients
May 17 / Zacks.com - Paid Partner Content
Zimmer Biomet: Strong Q1, Integration Synergy Continues
May 23 / Zacks.com - Paid Partner Content
Myriad Genetics: Test Revenues Strong, Currency Woes Stay
May 16 / Zacks.com - Paid Partner Content
Why Noble Energy, Grace, Boston Scientific Belong in Your Portfolio
May 20 / TheStreet.com - Paid Partner Content
VWR Corp Posts Strong Q1 Results; Gross Margins Weak
May 13 / Zacks.com - Paid Partner Content
Boston Scientific's Full-Body MRI SCS System Gets FDA Nod
May 20 / Zacks.com - Paid Partner Content
Boston Scientific (BSX): Q1 Earnings Beat amid CRM Woes
May 12 / Zacks.com - Paid Partner Content